⌘K

Home/Filings/4/0001140361-10-030636

4//SEC Filing

Mieyal Paul A 4

Accession 0001140361-10-030636

CIK 0001133869other

View on SEC.gov Company Profile

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 4:37 PM ET

Size

5.8 KB

Accession

0001140361-10-030636

Insider Transaction Report

Form 4

Period: 2010-07-26

Nile Therapeutics, Inc.NLTX

Director

Transactions

Award
Stock Option (Right to Buy)
2010-07-26+80,000→ 80,000 total
Exercise: $0.37From: 2011-07-26Exp: 2020-07-26→ Common Stock (80,000 underlying)

Footnotes (1)

[F1]These options have been assigned to Wexford Capital LP

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

Nile Therapeutics, Inc.

CIK 0001133869

Entity typeother

Related Parties

1

filerCIK 0001412471

Filing Metadata

Form type: 4
Filed: Jul 27, 8:00 PM ET
Accepted: Jul 28, 4:37 PM ET
Size: 5.8 KB

View on SEC.gov